KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 1 filers reported holding KRONOS BIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 4.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21 | -25.0% | 16,128 | 0.0% | 0.00% | – |
Q2 2023 | $28 | -51.7% | 16,128 | -59.4% | 0.00% | – |
Q1 2023 | $58 | +31.8% | 39,687 | +46.7% | 0.00% | – |
Q4 2022 | $44 | -99.9% | 27,053 | +51.5% | 0.00% | – |
Q3 2022 | $60,000 | -16.7% | 17,853 | -10.2% | 0.00% | – |
Q2 2022 | $72,000 | -6.5% | 19,877 | +93.6% | 0.00% | – |
Q1 2022 | $77,000 | – | 10,268 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,765,314 | $57,961,000 | 16.60% |
Omega Fund Management, LLC | 3,818,283 | $80,031,000 | 8.98% |
Wildcat Capital Management, LLC | 1,438,232 | $30,145,000 | 3.90% |
COMMODORE CAPITAL LP | 298,839 | $6,264,000 | 1.65% |
Perceptive Advisors | 2,421,142 | $50,747,000 | 0.74% |
Alphabet Inc. | 1,438,232 | $30,145,000 | 0.72% |
Artal Group S.A. | 1,317,954 | $27,624,000 | 0.62% |
Choate Investment Advisors | 393,436 | $8,246,000 | 0.53% |
PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $11,056,000 | 0.51% |
Coastal Bridge Advisors, LLC | 78,635 | $1,648,000 | 0.38% |